Drug Eluting Stent Zilver PTX vs Bare Metal Stent Zilver Flex
NCT ID: NCT05296031
Last Updated: 2023-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2013-03-01
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
NCT03551496
Zilver® PTX® in China
NCT02171962
ZENFlex-Registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty
NCT03751527
BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions
NCT02004951
Clinical Study of Focal Implant Used for Lower Extremity Post-angioplasty Dissection
NCT05562076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drug Eluting Stent (DES)
Drug Eluting Stent (DES). Zilver PTX.
Treatment with Zilver PTX Drug Eluting Stent (DES) in femoropopliteal lesions
Randomized trial comparing drug eluting stent Zilver PTX vs Bare metal stent Zilver Flex in critical limb ischemia and treatment of lesions in femoral and popliteal arteries
Bare Metal Stent (BMS)
Bare Metal Stent (BMS). Zilver Flex
Treatment with Zilver Flex Bare Metal Stent (BMS) in femoropopliteal lesions
Randomized trial comparing drug eluting stent Zilver PTX vs Bare metal stent Zilver Flex in critical limb ischemia and treatment of lesions in femoral and popliteal arteries
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment with Zilver PTX Drug Eluting Stent (DES) in femoropopliteal lesions
Randomized trial comparing drug eluting stent Zilver PTX vs Bare metal stent Zilver Flex in critical limb ischemia and treatment of lesions in femoral and popliteal arteries
Treatment with Zilver Flex Bare Metal Stent (BMS) in femoropopliteal lesions
Randomized trial comparing drug eluting stent Zilver PTX vs Bare metal stent Zilver Flex in critical limb ischemia and treatment of lesions in femoral and popliteal arteries
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Lesions in superficial femoral artery and popliteal artery (p1 -p2)
Target vessel 4-8mm
At least I 1 vessel runoff to the foot
Age \>18 years
Exclusion Criteria
Patient disapproval
Age \<18 years
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Skane University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Torbjorn Fransson
Principal Investigator, Consultant Vascular Surgeon
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TF2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.